VENT-03

· Ventus Therapeutics U.S., Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VENT-03, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus [Phase 2]

See pricing